Clinical Trials Directory

Trials / Completed

CompletedNCT02341469

A Trial of an Integrated E-diagnosis Assessment to Improve the Management of Childhood Illnesses in Burkina Faso

Integrated eDiagnosis Assessment (IeDA) for Children Under Five Years Old: a Stepped-wedge Randomized Cluster Trial of a Quality Improvement of the Management of Children Illnesses in Burkina Faso at the Primary Health Care Level

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7,200 (estimated)
Sponsor
London School of Hygiene and Tropical Medicine · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

In 2010, one in six children in Burkina Faso died before the age of five, mainly due to lack of access to quality health care services. Most of these deaths could have been avoided through cost-effective interventions. Ensuring that sick children receive adequate care in a country where 80% of the population lives in rural areas requires improved accessibility and high quality primary health care services. The Integrated Management of Childhood Illnesses strategy (IMCI) was developed by the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) in the 1990s and is an excellent way to improve the quality of country's child health services. However, in Burkina Faso IMCI suffers from a low level of adherence by health workers. According to a recent evaluation by the Ministry of Health (MoH), only 8.2% of children had benefited in 2012 from an consultation using IMCI guideline. Moreover, an analysis of children's records showed that only 15% of IMCI consultations were being correctly delivered and, for instance, only 34% of children with pneumonia who needed an antibiotic were prescribed the correct treatment. The obstacles to IMCI adoption in Burkina Faso are diverse and include inadequate training methods, shortage of material (papers, forms), lack of quality supervision by district executive teams, lack of integration between IMCI monitoring tools and the national health information system etc. The Integrated eDiagnosis Approach (IeDA) aims to address the poor quality of child health services in Burkina Faso by increasing the level of adherence to IMCI guidelines. IeDA is an innovative strategy combining information and communication technologies (using the Registre Electronique des Consultations \[REC\], an electronic IMCI patient record designed by Terre des hommes, Tdh) and a quality improvement approach. The approach has been piloted over three years in two different districts in the north of Burkina Faso, Tougan and Séguénéga. This medium scaling-up demonstration project will combine implementation and research components with a goal to enable national scaleup. Terre des hommes is in charge of the implementation of the project and the London School of Hygiene and Tropical Medicine (LSHTM) will coordinate the research component of the study in partnership with Centre Muraz. The primary hypothesis is that the Integrated eDiagnosis Approach will lead to improved adherence to IMCI guidelines and management of childhood illnesses in two regions (with a target of 75% of correct diagnoses and prescriptions).

Conditions

Interventions

TypeNameDescription
OTHERintegrated ediagnostic approach (IeDA)IeDA is a package of several interventions with the objective of improving the quality of child health care in health centres to ultimately decrease child morbidity and mortality. The components of IedA are described as follows: * REC: the IMCI protocol translated into a computer-based tool that aims to guide nurses during consultations. * The training of nurses on IMCI and REC. * A quality assurance mechanism through which each district and health centre is encouraged to find appropriate solutions in response to their local needs. * A supervision system conducted implemented by district managers to provide support and guidance to health centres. * A health information system based on data collected through the REC and fed back to the district managers and Heads of health centres.

Timeline

Start date
2014-09-01
Primary completion
2017-10-15
Completion
2017-10-15
First posted
2015-01-19
Last updated
2018-01-11

Locations

1 site across 1 country: Burkina Faso

Source: ClinicalTrials.gov record NCT02341469. Inclusion in this directory is not an endorsement.